THREE-YEAR RESULTS FROM THE EVOLVE II RANDOMIZED TRIAL: LATE CLINICAL OUTCOMES WITH BIORESORBABLE COMPARED TO PERMANENT POLYMER EVEROLIMUS-ELUTING
Kereiakes, Dean J., Meredith, Ian, Windecker, Stephan, Rodes-Cabau, Josep, Lee, Tommy, Reitman, Arthur, Erglis, Andrejs, Dorogy, Mark, Bertolet, Barry, Cannon, Louis, Airaksinen, Juhani, Siegel, CraigVolume:
69
Language:
english
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/s0735-1097(17)34359-0
Date:
March, 2017
File:
PDF, 332 KB
english, 2017